Showing posts with label heart attack. Show all posts
Showing posts with label heart attack. Show all posts

Wednesday, November 18, 2009

Heart Disease Found in Egyptian Mummies

 Hardening of the arteries has been detected in Egyptian mummies, some as old as 3,500 years, suggesting that the factors causing heart attack and stroke are not only modern ones; they afflicted ancient people, too.

Study results are appearing in the Nov. 18 issue of the Journal of the American Medical Association (JAMA) and are being presented Nov. 17 at the Scientific Session of the American Heart Association at Orlando, Fla.

"Atherosclerosis is ubiquitous among modern day humans and, despite differences in ancient and modern lifestyles, we found that it was rather common in ancient Egyptians of high socioeconomic status living as much as three millennia ago," says UC Irvine clinical professor of cardiology Dr. Gregory Thomas, a co-principal investigator on the study. "The findings suggest that we may have to look beyond modern risk factors to fully understand the disease."

The nameplate of the Pharaoh Merenptah (c. 1213-1203 BC) in the Museum of Egyptian Antiquities reads that, when he died at approximately age 60, he was afflicted with atherosclerosis, arthritis, and dental decay. Intrigued that atherosclerosis may have been widespread among ancient Egyptians, Thomas and a team of U.S. and Egyptian cardiologists, joined by experts in Egyptology and preservation, selected 20 mummies on display and in the basement of the Museum of Egyptian Antiquities for scanning on a Siemens 6 slice CT scanner during the week of Feb. 8, 2009.

The mummies underwent whole body scanning with special attention to the cardiovascular system. The researchers found that 9 of the 16 mummies who had identifiable arteries or hearts left in their bodies after the mummification process had calcification either clearly seen in the wall of the artery or in the path were the artery should have been. Some mummies had calcification in up to 6 different arteries.

Using skeletal analysis, the Egyptology and preservationist team was able to estimate the age at death for all the mummies and the names and occupations in the majority. Of the mummies who had died when they were older than 45, 7 of 8 had calcification and thus atherosclerosis while only 2 of 8 of those dying at an earlier age had calcification. Atherosclerosis did not spare women; vascular calcifications were observed in both male and female mummies.

The most ancient Egyptian afflicted with atherosclerosis was Lady Rai, who lived to an estimated age of 30 to 40 years around 1530 BC and had been the nursemaid to Queen Ahmose Nefertiri. To put this in context, Lady Rai lived about 300 years prior to the time of Moses and 200 prior to King Tutankhamun (Tut).

In those mummies whose identities could be determined, all were of high socioeconomic status, generally serving in the court of the Pharaoh or as priests or priestess. While the diet of any one mummy could not be determined, eating meat in the form of cattle, ducks and geese was not uncommon during these times.

"While we do not know whether atherosclerosis caused the demise of any of the mummies in the study, we can confirm that the disease was present in many," Thomas says.

In addition to Thomas, Dr. Adel Allam of the Al Azhar Medical School in Cairo, Egypt, is the study's co-principal investigator. Dr. Randall Thompson of the Mid America Heart Institute in Kansas City, Mo.; Dr. L. Samuel Wann of the Wisconsin Heart Hospital in Milwaukee; and Dr. Michael Miyamoto of UC San Diego also contributed to the JAMA report.

The Egyptology and preservationist team consisted of Abd el-Halim Nur el-Din and Gomma Ab el-Maksoud of Cairo University; Ibrahem Badr of the Institute of Restoration in Alexandria, Egypt; Hany Abd el-Amer of the National Research Center in Dokki, Giza, Egypt.

The authors express their appreciation to Zahi Hawass, secretary general of the Supreme Council of Antiquities, for allowing them to scan these mummies and perform this investigation.
Adapted from materials provided by University of California - Irvine, via EurekAlert!, a service of AAAS.

Tuesday, October 13, 2009

Common Pain Cream Could Protect Heart During Attack, Study Shows

New research from the University of Cincinnati shows that a common, over-the-counter pain salve rubbed on the skin during a heart attack could serve as a cardiac-protectant, preventing or reducing damage to the heart while interventions are administered.

These findings are published in the Sept. 14 edition of the journal Circulation.

Keith Jones, PhD, a researcher in the department of pharmacology and cell biophysics, and scientists in his lab have found that applying capsaicin to specific skin locations in mice caused sensory nerves in the skin to trigger signals in the nervous system. These signals activate cellular “pro-survival” pathways in the heart which protect the muscle.

Capsaicin is the main component of chili peppers and produces a hot sensation. It is also the active ingredient in several topical medications used for temporary pain relief.

Capsaicin is approved for use by the U.S. Food and Drug Administration.

Jones is working with Neal Weintraub, MD, a UC Health cardiologist and director of UC’s cardiovascular diseases division, and other clinicians to construct a translational plan to test capsaicin in a human population.

“Topical capsaicin has no known serious adverse effects and could be easily applied in an ambulance or emergency room setting well in advance of coronary tissue death,” Jones says. “If proven effective in humans, this therapy has the potential to reduce injury and/or death in the event of a coronary blockage, thereby reducing the extent and consequences of heart attack.”

Researchers observed an 85 percent reduction in cardiac cell death when capsaicin was used.

They also found that a small incision made on the abdomen triggered an 81 percent reduction.

“Both this and the capsaicin effect are shown to work through similar neurological mechanisms,” Jones says. “These are the most powerful cardioprotective effects recorded to date.

“This is a form of remote cardioprotection, using a skin stimulus that activates cardioprotection long before the blocked coronary artery is opened.”

Weintraub adds that this finding offers an important distinction between existing therapies.

“All of the current interventions require the vessel to be opened before doctors can act, and since it takes time to elicit protection, tissue dies,” he says. “This treatment will protect the heart before the vessel is opened while producing a strong protective effect that is already active when we open the vessel.”

Jones and Weintraub think that skin—the main sensor and largest human body organ—has evolved to protect animals, including humans, in a variety of ways.

“By activating these sensors in the nervous system, via skin, we think that a response to preserve and protect the heart is triggered,” Weintraub says.

“We think that this technique is fooling the body into sending out protective signals,” Jones adds. “This may be similar to the way certain acupuncture treatments work; there may be a neurological basis. In a broad sense, this work may provide a ‘Rosetta stone’ for translating alternative medicine techniques—like acupuncture—to Western medicine. Perhaps we can understand the biological mechanisms of how alternative treatments may be successful for patients.”

Now, researchers will further explore this concept by investigating which sensors are associated with certain aspects of organ protection—and how much of specific stimuli are needed to produce the desired responses.

“This could help create favorable outcomes for those who are experiencing stroke, shock or are in need of an organ transplant, and the best part is that it is done non-invasively and is relatively inexpensive,” Jones says.

But he warns against rubbing capsaicin on your belly if you feel like you are having a heart attack.

“We don’t know if it will work for all indications, for all patients, and we don’t know if it will work over an extended amount of time,” he says. “A major goal is testing this therapy in clinical trials, but we still need to study more about dosage and application—where we put it on the body for the best results. However, this has tremendous clinical potential and could eventually save lives.”

This study was funded by the National Institutes of Health and by the University of Cincinnati. Jones and Weintraub have filed a patent for this funding but have received no honoraria from the makers of capsaicin.
Adapted from materials provided by University of Cincinnati Academic Health Center.